Risk factors for bladder injury during cesarean delivery.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Marco A Pelosi.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In the mid-1990s, the authors introduced a minimally invasive system of cesarean delivery. This article illustrates the improvements made since the technique's initial publication. The Pelosi Minimalist Cesarean procedure is the simplest and least traumatic approach of cesarean delivery. The procedure described herein features a short operating time, minimal instrumentation, reduced surgical dissection, decreased postoperative pain, and reduced risk of blood loss, infection, and wound complications. It is easily learned and cost-effective, with a brief postoperative recovery period.
T he authors' technique of minilaparotomy hysterotomy is a new modality that combines the technical benefits of conventional laparotomy with the minimally invasive convalescent and cosmetic advantages of laparoscopic surgery. For patients in whom vaginal hysterectomy is considered contraindicated, this procedure offers an effective and safe minimal access alternative. This redesigned minilaparotomy approach relies on traditional open techniques and experience instrumentation that avoid the cost of expensive equipment, long learning curve, and prolonged operating time associated with laparoscopic surgery, as well as the convalescent disadvantages of a standard laparotomy.
T his innovative sling system places the sling between the obturator foramens using a perineal approach while preserving an intact retropubic space. Potential complications associated with tension-free sling systems that use needle-carrier placement through the retropubic space, such as the tension-free vaginal tape (TVT, Gynecare, Ethicon, Somerville, NJ, USA), are eliminated and routine cystoscopy is not required. The procedure is effective and safe for the primary treatment of stress urinary incontinence in patients with urethral hypermobility, intrinsic sphincter deficiency, or both. It is equally efficient in treatment of recurrent and mixed urinary incontinence. Short-term results are similar to those of the retropubic tension-free slings.
BACKGROUND: A pilot study was made to assess the efficacy and safety of a new nonabsorbable adhesion barrier (Shelhigh Dome Pericondial Patch No-React Treated) in reducing adhesion after extensive myomectomy by laparotomy with a planned second-look laparoscopy. METHODS: In 20 patients after extensive myomectomy and full thickness uterine wall reconstruction, the patch was sutured over the uterus. Second-look laparoscopy was performed 6 weeks postoperatively. Third-look laparoscopy was done in 3 patients. RESULTS: Surgeries were completed without intraoperative or postoperative complications. No problems related to the patch were encountered including the need for its removal. At laparoscopy no adhesions between the abdominal wall, bladder, small bowel, or sigmoid colon to the uterus were noticed. A thin layer of the omental edge covered the patch that was securely anchored to the uterine fundus. The mean follow-up was 13 months. CONCLUSIONS: These findings suggest benefits with this new bovine/porcine pericardial adhesion barrier for myomectomy. Controlled clinical trials are warranted.
BACKGROUND AND PURPOSE: We report our initial experience using a new suburethral sling made from bovine pericardium for the treatment of urinary incontinence. To prevent rolling and curling of the sling, a unique anti-roll clip is incorporated into the UroPatch. In addition, the sling has a series of perforations that create evenly distributed tissue integration and avoid delayed seroma or hematoma formation, thereby reducing the risk of sling rejection, infection, and erosion. PATIENTS AND METHODS: Twenty-two female patients underwent suburethral sling procedures using the UroPatch. All patients demonstrated urethral hypermobility, intrinsic sphincteric deficiency, or both. Five patients had previous surgical treatment for urinary incontinence. RESULTS: All operations were completed successfully. No intraoperative or postoperative complications occurred. There was no evidence of local or systemic reaction to the UroPatch in any of the patients. With a mean follow-up of 20 months, sling rejection, erosion, or infection has not been demonstrated, and no sling required removal to date. Urinary incontinence was corrected in all but one case. CONCLUSION: The results of this pilot study suggest that the UroPatch is a promising alternative to current slings for the treatment of female urinary incontinence.